Trastuzumab drug improves long-term survival of patients with HER-2 positive breast c

[News]

VCU Massey Cancer Center physician-researcher Charles E. Geyer, Jr., M.D., was the National Protocol Officer for one component of a large national study involving two National Cancer Institute-supported clinical trials that demonstrated that trastuzumab significantly improves the long-term survival of HER-2 positive breast cancer patients.

More... (http://www.news-medical.net/news/20141216/Trastuzumab-drug-improves-long-term-survival-of-patients-with-HER-2-positive-breast-cancer.aspx)